DMF Melphalan Hydrochloride USP CAS 3223-07-2 Anti Cancer Drug Substance

Product Description

Melphalan Hydrochloride API USP CAS No.3223-07-2 

Melphalan Hydrochloride is a bifunctional alkylating agent  also known as L-phenylalanine mustard for the treatment of multiple myeloma.

Xi'an Libang Pharmaceutical Co..Ltd developed and lauched Melphalan Hydrochloride as the first generic in China in 2022.

Molecular formula: C₁₃H₁₉Cl₃N₂O₂· HCl

Molecular Weight: 341.66

CAS registry number:3223-07-2

Chemical Name:4-[bis(2-chloroethyl)amino]-L-phenylalanine hydrochloride

Description

White crystalline powder with specific odor.

Solubility

Freely soluble in methanol and diluted hydrochloric acid, soluble in ethanol and slightly insoluble in water.

Specific rotation:-12° to -6°.

Melting point:200°C to 207°C, decomposes when melting.

Xi'an Libang Pharmaceutical Co..Ltd established a strict in-house quality specification for Melphalan Hydrochloride and it founded in 1996 with a location in Xi’an City of China, the center of the northwest pharmaceutical industry, is specialized in research, development, production and distribution of specialty pharmaceutical products. As the first and also largest supplier of generic Propofol in China, LIBANG started its business and subsequently launched a broad portfolio finished dosage forms covering s, cardiovascular, antineoplastic, clinical nutrition etc.

With more than 20 years growth, LIBANG has transformed into an integrated health care solution provider, LIBANG HEALTHCARE GROUP, with diversified fields covering high value-added APIs, pharmaceutical excipients, prescription drugs, OTC products, biomedicine, medical devices.

LIBANG is a technology-driven firm, with more than 8% of the annual sales revenues devoted to research and innovation, establishing a unique R&D platform to proactively follow the latest pharmaceutical technology frontier.

LIBANG now is one of Top 100 China’s Pharmaceutical Industries and also listed in the Top 20 The Most Potential Chinese Pharmaceuticals that was rated by the IMS Health.